A Highly Sensitive Amperometric Glutamate Oxidase Microbiosensor Based on a Reduced Graphene Oxide/Prussian Blue Nanocube/Gold Nanoparticle Composite Film-Modified Pt Electrode

Abstract

A simple method that relies only on an electrochemical workstation has been investigated to fabricate a highly sensitive glutamate microbiosensor for potential neuroscience applications. In this study, in order to develop the highly sensitive glutamate electrode, a 100 µm platinum wire was modified by the electrochemical deposition of gold nanoparticles, Prussian blue nanocubes, and reduced graphene oxide sheets, which increased the electroactive surface area; and the chitosan layer, which provided a suitable environment to bond the glutamate oxidase. The optimization of the fabrication procedure and analytical conditions is described. The modified electrode was characterized using field emission scanning electron microscopy, impedance spectroscopy, and cyclic voltammetry. The results exhibited its excellent sensitivity for glutamate detection (LOD = 41.33 nM), adequate linearity (50 nM–40 µM), ascendant reproducibility (RSD = 4.44%), and prolonged stability (more than 30 repetitive potential sweeps, two-week lifespan). Because of the important role of glutamate in neurotransmission and brain function, this small-dimension, high-sensitivity glutamate electrode is a promising tool in neuroscience research.

The Application of Prussian Blue Nanoparticles in Tumor Diagnosis and Treatment

“…A tuned core-shell, hollow, or substrate-supported PB/PBA framework enables electrolyte diffusion to enhance electrochemical performances [18]. Furthermore, the application of different nanomaterials such as graphene, carbon nanotubes, quantum dots, magnetic particles, and gold nanoparticles deposited on PB/PBA offer new avenues to increase the sensitivity [19,20]. In previous studies, PB/PBA-based biosensors were considered to be one of the most efficient electron-transfer mediators for applications including the determination of tumor markers, antihypertensive drugs, glucose, lactate, ascorbic acid, DNA, ions, and pH [21][22][23][24][25][26][27][28].…”

N-Doped Reduced Graphene Oxide/Gold Nanoparticles Composite as an Improved Sensing Platform for Simultaneous Detection of Dopamine, Ascorbic Acid, and Uric Acid

“…Aiming to enhance the electrochemical sensing characteristics of these rGOs, several authors have proposed their modification with different metallic nanoparticles. Among them, gold nanoparticles (AuNPs) have attracted considerable attention because of their chemical stability [16,17] and well-developed electrochemically active surface area [18,19]. In addition, the electron transport properties of the as-obtained rGOs can be further improved by nitrogen doping [20,21].…”

Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature

“…128 In addition, studies are also available on graphene-based nanocarriers for example reduced graphene and graphene oxide. 129,130 Central nervous system (CNS) related disorders are characterized by a wide-ranging brain illness with various disabilities. 131 A new paradigm for CNS-related disorders (Alzheimer's, Parkinsonism) is provided by the nanocarriers approach.…”